Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

Authors :: McMurray JJ
Uno H
Jarolim P
Desai AS
de Zeeuw D
Eckardt KU
Ivanovich P
Levey AS
Lewis EF
McGill JB
Parfrey P
Parving HH
Toto RM
Solomon SD
Pfeffer MA
Source :: American Heart Journal; Oct2011, Vol. 162 Issue 4, p748-755.e3, 1p
Publication Year :: 2011

Tools